{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:20:34Z","timestamp":1790659234947,"version":"4.1.0"},"reference-count":154,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T00:00:00Z","timestamp":1623024000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The treatment of type 2 diabetes patients with bromocriptine-QR, a unique, quick release micronized formulation of bromocriptine, improves glycemic control and reduces adverse cardiovascular events. While the improvement of glycemic control is largely the result of improved postprandial hepatic glucose metabolism and insulin action, the mechanisms underlying the drug\u2019s cardioprotective effects are less well defined. Bromocriptine is a sympatholytic dopamine agonist and reduces the elevated sympathetic tone, characteristic of metabolic syndrome and type 2 diabetes, which potentiates elevations of vascular oxidative\/nitrosative stress, known to precipitate cardiovascular disease. Therefore, this study investigated the impact of bromocriptine treatment upon biomarkers of vascular oxidative\/nitrosative stress (including the pro-oxidative\/nitrosative stress enzymes of NADPH oxidase 4, inducible nitric oxide (iNOS), uncoupled endothelial nitric oxide synthase (eNOS), the pro-inflammatory\/pro-oxidative marker GTP cyclohydrolase 1 (GTPCH 1), and the pro-vascular health enzyme, soluble guanylate cyclase (sGC) as well as the plasma level of thiobarbituric acid reactive substances (TBARS), a circulating marker of systemic oxidative stress), in hypertensive SHR rats held on a high fat diet to induce metabolic syndrome. Inasmuch as the central nervous system (CNS) dopaminergic activities both regulate and are regulated by CNS circadian pacemaker circuitry, this study also investigated the time-of-day-dependent effects of bromocriptine treatment (10 mg\/kg\/day at either 13 or 19 h after the onset of light (at the natural waking time or late during the activity period, respectively) among animals held on 14 h daily photoperiods for 16 days upon such vascular biomarkers of vascular redox state, several metabolic syndrome parameters, and mediobasal hypothalamic (MBH) mRNA expression levels of neuropeptides neuropeptide Y (NPY) and agouti-related protein (AgRP) which regulate the peripheral fuel metabolism and of mRNA expression of other MBH glial and neuronal cell genes that support such metabolism regulating neurons in this model system. Such bromocriptine treatment at ZT 13 improved (reduced) biomarkers of vascular oxidative\/nitrosative stress including plasma TBARS level, aortic NADPH oxidase 4, iNOS and GTPCH 1 levels, and improved other markers of coupled eNOS function, including increased sGC protein level, relative to controls. However, bromocriptine treatment at ZT 19 produced no improvement in either coupled eNOS function or sGC protein level. Moreover, such ZT 13 bromocriptine treatment reduced several metabolic syndrome parameters including fasting insulin and leptin levels, as well as elevated systolic and diastolic blood pressure, insulin resistance, body fat store levels and liver fat content, however, such effects of ZT 19 bromocriptine treatment were largely absent versus control. Finally, ZT 13 bromocriptine treatment reduced MBH NPY and AgRP mRNA levels and mRNA levels of several MBH glial cell\/neuronal genes that code for neuronal support\/plasticity proteins (suggesting a shift in neuronal structure\/function to a new metabolic control state) while ZT 19 treatment reduced only AgRP, not NPY, and was with very little effect on such MBH glial cell genes expression. These findings indicate that circadian-timed bromocriptine administration at the natural circadian peak of CNS dopaminergic activity (that is diminished in insulin resistant states), but not outside this daily time window when such CNS dopaminergic activity is naturally low, produces widespread improvements in biomarkers of vascular oxidative stress that are associated with the amelioration of metabolic syndrome and reductions in MBH neuropeptides and gene expressions known to facilitate metabolic syndrome. These results of such circadian-timed bromocriptine treatment upon vascular pathology provide potential mechanisms for the observed marked reductions in adverse cardiovascular events with circadian-timed bromocriptine-QR therapy (similarly timed to the onset of daily waking as in this study) of type 2 diabetes subjects and warrant further investigations into related mechanisms and the potential application of such intervention to prediabetes and metabolic syndrome patients as well.<\/jats:p>","DOI":"10.3390\/ijms22116142","type":"journal-article","created":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T13:25:43Z","timestamp":1623072343000},"page":"6142","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Time-of-Day-Dependent Effects of Bromocriptine to Ameliorate Vascular Pathology and Metabolic Syndrome in SHR Rats Held on High Fat Diet"],"prefix":"10.3390","volume":"22","author":[{"given":"Michael","family":"Ezrokhi","sequence":"first","affiliation":[{"name":"VeroScience LLC, Tiverton, RI 02878, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahong","family":"Zhang","sequence":"additional","affiliation":[{"name":"VeroScience LLC, Tiverton, RI 02878, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuqin","family":"Luo","sequence":"additional","affiliation":[{"name":"VeroScience LLC, Tiverton, RI 02878, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8329-3341","authenticated-orcid":false,"given":"Anthony H.","family":"Cincotta","sequence":"additional","affiliation":[{"name":"VeroScience LLC, Tiverton, RI 02878, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,6,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1586\/17446651.2016.1131119","article-title":"Bromocriptine-QR therapy for the management of type 2 diabetes mellitus: Developmental basis and therapeutic profile summary","volume":"11","author":"Raskin","year":"2016","journal-title":"Expert Rev. Endocrinol. Metab."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e12563","DOI":"10.1111\/jne.12563","article-title":"Circadian peak dopaminergic activity response at the biological clock pacemaker (suprachiasmatic nucleus) area mediates the metabolic responsiveness to a high-fat diet","volume":"30","author":"Luo","year":"2018","journal-title":"J. Neuroendocrinol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e00139","DOI":"10.1002\/edm2.139","article-title":"Circadian-timed dopamine agonist treatment reverses high-fat diet-induced diabetogenic shift in ventromedial hypothalamic glucose sensing","volume":"3","author":"Stoelzel","year":"2020","journal-title":"Endocrinol. Diabetes Metab."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1046\/j.1365-2826.2003.01019.x","article-title":"Daily rhythms in glucose metabolism: Suprachiasmatic nucleus output to peripheral tissue","volume":"15","year":"2003","journal-title":"J. Neuroendocrinol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1749-6632.2010.05800.x","article-title":"Hypothalamic control of energy metabolism via the autonomic nervous system","volume":"1212","author":"Kalsbeek","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.brainres.2010.04.028","article-title":"Modulation of the mesolimbic dopamine system by leptin","volume":"1350","author":"Opland","year":"2010","journal-title":"Brain Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.neuroscience.2009.02.007","article-title":"Deficits of mesolimbic dopamine neurotransmission in rat dietary obesity","volume":"159","author":"Geiger","year":"2009","journal-title":"Neuroscience"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1096\/fj.08-110759","article-title":"Evidence for defective mesolimbic dopamine exocytosis in obesity-prone rats","volume":"22","author":"Geiger","year":"2008","journal-title":"FASEB J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1097\/00001756-199907130-00015","article-title":"Suprachiasmatic nuclei monoamine metabolism of glucose tolerant versus intolerant hamsters","volume":"10","author":"Luo","year":"1999","journal-title":"Neuroreport"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1097\/00001756-199711100-00016","article-title":"Dopaminergic neurotoxin administration to the area of the suprachiasmatic nuclei induces insulin resistance","volume":"8","author":"Luo","year":"1997","journal-title":"Neuroreport"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13098-021-00630-x","article-title":"Experimental dopaminergic neuron lesion at the area of the biological clock pacemaker, suprachiasmatic nuclei (SCN) induces metabolic syndrome in rats","volume":"13","author":"Luo","year":"2021","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e00101","DOI":"10.1002\/edm2.101","article-title":"Circadian-timed quick-release bromocriptine lowers elevated resting heart rate in patients with type 2 diabetes mellitus","volume":"3","author":"Chamarthi","year":"2020","journal-title":"Endocrinol. Diabetes Metab."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1758-5996-6-104","article-title":"Neuroendocrine and metabolic components of dopamine agonist amelioration of metabolic syndrome in SHR rats","volume":"6","author":"Ezrokhi","year":"2014","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1159\/000054522","article-title":"Dopaminergic agonists normalize elevated hypothalamic neuropeptide Y and corticotropin-releasing hormone, body weight gain, and hyperglycemia in ob\/ob mice","volume":"71","author":"Bina","year":"2000","journal-title":"Neuroendocrinology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.2337\/dc09-2009","article-title":"Randomized clinical trial of quick-release bromocriptine among patients with type 2 diabetes on overall safety and cardiovascular outcomes","volume":"33","author":"Gaziano","year":"2010","journal-title":"Diabetes Care"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e002279","DOI":"10.1161\/JAHA.112.002279","article-title":"Effect of bromocriptine-QR (a quick-release formulation of bromocriptine mesylate) on major adverse cardiovascular events in type 2 diabetes subjects","volume":"1","author":"Gaziano","year":"2012","journal-title":"J. Am. Heart Assoc."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"157698","DOI":"10.1155\/2015\/157698","article-title":"Timed Bromocriptine-QR Therapy Reduces Progression of Cardiovascular Disease and Dysglycemia in Subjects with Well-Controlled Type 2 Diabetes Mellitus","volume":"2015","author":"Chamarthi","year":"2015","journal-title":"J. Diabetes Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1080\/00325481.2016.1243003","article-title":"Impact of bromocriptine-QR therapy on cardiovascular outcomes in type 2 diabetes mellitus subjects on metformin","volume":"128","author":"Chamarthi","year":"2016","journal-title":"Postgrad. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.coph.2020.11.007","article-title":"Circadian influence on inflammatory response during cardiovascular disease","volume":"57","author":"Aziz","year":"2020","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Man, A.W.C., Li, H., and Xia, N. (2021). Circadian Rhythm: Potential Therapeutic Target for Atherosclerosis and Thrombosis. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22020676"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3132\/dvdr.2008.015","article-title":"Molecular clocks, type 2 diabetes and cardiovascular disease","volume":"5","author":"Prasai","year":"2008","journal-title":"Diab. Vasc. Dis. Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.sleep.2006.12.010","article-title":"Potential role for peripheral circadian clock dyssynchrony in the pathogenesis of cardiovascular dysfunction","volume":"8","author":"Young","year":"2007","journal-title":"Sleep Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1161\/ATVBAHA.107.144923","article-title":"Peripheral circadian clocks in the vasculature","volume":"27","author":"Reilly","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1254\/jphs.FMJ06003X2","article-title":"Circadian rhythms in the CNS and peripheral clock disorders: Role of the biological clock in cardiovascular diseases","volume":"103","author":"Maemura","year":"2007","journal-title":"J. Pharmacol. Sci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1254\/jphs.FMJ06003X3","article-title":"Circadian rhythms in the CNS and peripheral clock disorders: The circadian clock and hyperlipidemia","volume":"103","author":"Kudo","year":"2007","journal-title":"J. Pharmacol. Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.tem.2009.03.005","article-title":"eNOS, metabolic syndrome and cardiovascular disease","volume":"20","author":"Huang","year":"2009","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1161\/01.CIR.0000012748.58444.08","article-title":"Mechanisms of increased vascular superoxide production in human diabetes mellitus: Role of NAD(P)H oxidase and endothelial nitric oxide synthase","volume":"105","author":"Guzik","year":"2002","journal-title":"Circulation"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"413","DOI":"10.9734\/BJMMR\/2012\/1479","article-title":"Endothelial Dysfunction: An Early Cardiovascular Risk Marker in Asymptomatic Obese Individuals with Prediabetes","volume":"2","author":"Gupta","year":"2012","journal-title":"Br. J. Med. Med. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1161\/CIRCULATIONAHA.105.602532","article-title":"Endothelial nitric oxide synthase in vascular disease: From marvel to menace","volume":"113","author":"Forstermann","year":"2006","journal-title":"Circulation"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/sj.ijo.0801995","article-title":"Obesity, atherosclerosis and the vascular endothelium: Mechanisms of reduced nitric oxide bioavailability in obese humans","volume":"26","author":"Williams","year":"2002","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1254\/jphs.FMJ04006X4","article-title":"Malfunction of vascular control in lifestyle-related diseases: Mechanisms underlying endothelial dysfunction in the insulin-resistant state","volume":"96","author":"Shinozaki","year":"2004","journal-title":"J. Pharmacol. Sci."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2174\/156720207779940653","article-title":"Oxidative stress biology and cell injury during type 1 and type 2 diabetes mellitus","volume":"4","author":"Maiese","year":"2007","journal-title":"Curr. Neurovasc Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.lfs.2005.06.029","article-title":"Disturbances in nitric oxide\/cyclic guanosine monophosphate system in SHR\/NDmcr-cp rats, a model of metabolic syndrome","volume":"78","author":"Kagota","year":"2006","journal-title":"Life Sci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/00004872-200203000-00022","article-title":"Reduction of the soluble cyclic GMP vasorelaxing system in the vascular wall of stroke-prone spontaneously hypertensive rats: Effect of the alpha1 -receptor blocker doxazosin","volume":"20","author":"Gomez","year":"2002","journal-title":"J. Hypertens"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1161\/01.HYP.37.2.313","article-title":"Pulse pressure, aortic reactivity, and endothelium dysfunction in old hypertensive rats","volume":"37","author":"Renaud","year":"2001","journal-title":"Hypertension"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1097\/01.fjc.0000238593.67191.e2","article-title":"Effect of nebivolol on endothelial nitric oxide and peroxynitrite release in hypertensive animals: Role of antioxidant activity","volume":"48","author":"Mason","year":"2006","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.niox.2006.04.264","article-title":"Elevated circulating levels of markers of oxidative-nitrative stress and inflammation in a genetic rat model of metabolic syndrome","volume":"15","author":"Yamaguchi","year":"2006","journal-title":"Nitric Oxide"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"459","DOI":"10.18388\/abp.2004_3584","article-title":"Endothelial NADH\/NADPH-dependent enzymatic sources of superoxide production: Relationship to endothelial dysfunction","volume":"51","author":"Kalinowski","year":"2004","journal-title":"Acta Biochim. Pol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"S170","DOI":"10.2337\/dc08-s247","article-title":"NADPH oxidases, reactive oxygen species, and hypertension: Clinical implications and therapeutic possibilities","volume":"31","author":"Paravicini","year":"2008","journal-title":"Diabetes Care"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1161\/01.RES.0000163631.07205.fb","article-title":"NAD(P)H oxidase-dependent self-propagation of hydrogen peroxide and vascular disease","volume":"96","author":"Cai","year":"2005","journal-title":"Circ. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.2174\/13816128113196660746","article-title":"Molecular mechanisms of endothelial NO synthase uncoupling","volume":"20","author":"Luo","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.freeradbiomed.2007.12.025","article-title":"Regulation of smooth muscle by inducible nitric oxide synthase and NADPH oxidase in vascular proliferative diseases","volume":"44","author":"Ginnan","year":"2008","journal-title":"Free Radic Biol. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"H2878","DOI":"10.1152\/ajpheart.01144.2006","article-title":"Profound biopterin oxidation and protein tyrosine nitration in tissues of ApoE-null mice on an atherogenic diet: Contribution of inducible nitric oxide synthase","volume":"293","author":"Upmacis","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"117821","DOI":"10.1016\/j.lfs.2020.117821","article-title":"Molecular mechanisms by which iNOS uncoupling can induce cardiovascular dysfunction during sepsis: Role of posttranslational modifications (PTMs)","volume":"255","author":"Sharawy","year":"2020","journal-title":"Life Sci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"164","DOI":"10.2174\/13894501113146660227","article-title":"Inducible nitric oxide synthase as a possible target in hypertension","volume":"15","author":"Lacchini","year":"2014","journal-title":"Curr. Drug Targets"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1172\/JCI0213265","article-title":"Cardiomyocyte overexpression of iNOS in mice results in peroxynitrite generation, heart block, and sudden death","volume":"109","author":"Mungrue","year":"2002","journal-title":"J. Clin. Investig."},{"key":"ref_47","first-page":"77","article-title":"Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite","volume":"75","author":"Buttery","year":"1996","journal-title":"Lab. Investig."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"666","DOI":"10.2337\/db06-0699","article-title":"Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes","volume":"56","author":"Thum","year":"2007","journal-title":"Diabetes"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1161\/01.ATV.0000168896.64927.bb","article-title":"Vascular consequences of endothelial nitric oxide synthase uncoupling for the activity and expression of the soluble guanylyl cyclase and the cGMP-dependent protein kinase. Publication and Online Material","volume":"25","author":"Munzel","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1172\/JCI200314172","article-title":"Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension","volume":"111","author":"Landmesser","year":"2003","journal-title":"J. Clin. Investig."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1161\/01.RES.0000187447.03525.72","article-title":"Stoichiometric relationships between endothelial tetrahydrobiopterin, endothelial NO synthase (eNOS) activity, and eNOS coupling in vivo: Insights from transgenic mice with endothelial-targeted GTP cyclohydrolase 1 and eNOS overexpression","volume":"97","author":"Bendall","year":"2005","journal-title":"Circ. Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1089\/ars.2007.1989","article-title":"Nitric oxide, tetrahydrobiopterin, oxidative stress, and endothelial dysfunction in hypertension","volume":"10","author":"Schulz","year":"2008","journal-title":"Antioxid. Redox. Signal."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.npep.2004.06.003","article-title":"NPY and cohorts in regulating appetite, obesity and metabolic syndrome: Beneficial effects of gene therapy","volume":"38","author":"Kalra","year":"2004","journal-title":"Neuropeptides"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.diabet.2013.11.002","article-title":"Central orchestration of peripheral nutrient partitioning and substrate utilization: Implications for the metabolic syndrome","volume":"40","author":"Denis","year":"2014","journal-title":"Diabetes Metab."},{"key":"ref_55","first-page":"99","article-title":"Activation of hypothalamic NPY, AgRP, MC4R, AND IL-6 mRNA levels in young Lewis rats with early-life diet-induced obesity","volume":"43","author":"Stofkova","year":"2009","journal-title":"Endocr. Regul."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.molmet.2013.10.002","article-title":"Central action of FGF19 reduces hypothalamic AGRP\/NPY neuron activity and improves glucose metabolism","volume":"3","author":"Marcelin","year":"2014","journal-title":"Mol. Metab."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1017\/S0007114509990729","article-title":"Experimental rat models to study the metabolic syndrome","volume":"102","year":"2009","journal-title":"Br. J. Nutr."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"R277","DOI":"10.1152\/ajpregu.00758.2002","article-title":"Vascular NAD(P)H oxidases: Specific features, expression, and regulation","volume":"285","author":"Lassegue","year":"2003","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.mam.2004.09.002","article-title":"The basics about nitric oxide","volume":"26","author":"Bruckdorfer","year":"2005","journal-title":"Mol. Asp. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cardiores.2005.06.021","article-title":"Hydrogen peroxide regulation of endothelial function: Origins, mechanisms, and consequences","volume":"68","author":"Cai","year":"2005","journal-title":"Cardiovasc. Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1152\/physrev.00029.2006","article-title":"Nitric oxide and peroxynitrite in health and disease","volume":"87","author":"Pacher","year":"2007","journal-title":"Physiol. Rev."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"5839","DOI":"10.1073\/pnas.1804932115","article-title":"Oxygen radicals, nitric oxide, and peroxynitrite: Redox pathways in molecular medicine","volume":"115","author":"Radi","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3164\/jcbn.19-119","article-title":"Reactive oxygen species in cardiovascular health and disease: Special references to nitric oxide, hydrogen peroxide, and Rho-kinase","volume":"66","author":"Shimokawa","year":"2020","journal-title":"J. Clin. Biochem. Nutr."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.redox.2016.08.015","article-title":"Redox signaling in cardiovascular pathophysiology: A focus on hydrogen peroxide and vascular smooth muscle cells","volume":"9","author":"Byon","year":"2016","journal-title":"Redox Biol."},{"key":"ref_65","first-page":"8","article-title":"Hydrogen peroxide activation of endothelial cell-associated MMPs during VCAM-1-dependent leukocyte migration","volume":"52","year":"2006","journal-title":"Cell Mol. Biol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"H7","DOI":"10.1152\/ajpheart.00637.2004","article-title":"Hemodynamic and biochemical adaptations to vascular smooth muscle overexpression of p22phox in mice","volume":"288","author":"Laude","year":"2005","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1161\/hq1001.097028","article-title":"Induction of endothelial NO synthase by hydrogen peroxide via a Ca(2+)\/calmodulin-dependent protein kinase II\/janus kinase 2-dependent pathway","volume":"21","author":"Cai","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1161\/01.RES.86.3.347","article-title":"Transcriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression by hydrogen peroxide","volume":"86","author":"Drummond","year":"2000","journal-title":"Circ. Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/10623320490482619","article-title":"Peroxynitrite and vascular endothelial dysfunction in diabetes mellitus","volume":"11","author":"Zou","year":"2004","journal-title":"Endothelium"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1254\/jphs.SC0040146","article-title":"Reduction of GTP cyclohydrolase I feedback regulating protein expression by hydrogen peroxide in vascular endothelial cells","volume":"97","author":"Ishii","year":"2005","journal-title":"J. Pharmacol. Sci."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1089\/ars.2006.1446","article-title":"Redox control of calcium channels: From mechanisms to therapeutic opportunities","volume":"9","author":"Hool","year":"2007","journal-title":"Antioxid. Redox Signal."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1161\/01.HYP.0000157169.27818.ae","article-title":"Mitochondria-derived reactive oxygen species and vascular MAP kinases: Comparison of angiotensin II and diazoxide","volume":"45","author":"Kimura","year":"2005","journal-title":"Hypertension"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1089\/ars.2006.8.2143","article-title":"Role of thioredoxin in cell growth through interactions with signaling molecules","volume":"8","author":"Yoshioka","year":"2006","journal-title":"Antioxid. Redox Signal."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1161\/01.ATV.20.10.2175","article-title":"Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology","volume":"20","author":"Griendling","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1089\/152308603770380115","article-title":"Role of NADPH oxidases in the control of vascular gene expression","volume":"5","author":"Brandes","year":"2003","journal-title":"Antioxid. Redox. Signal."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1161\/01.ATV.0000043452.30772.18","article-title":"The reactive adventitia: Fibroblast oxidase in vascular function","volume":"22","author":"Rey","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1136\/hrt.2003.029397","article-title":"Novel NAD(P)H oxidases in the cardiovascular system","volume":"90","author":"Griendling","year":"2004","journal-title":"Heart"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Perez-Torres, I., Manzano-Pech, L., Rubio-Ruiz, M.E., Soto, M.E., and Guarner-Lans, V. (2020). Nitrosative Stress and Its Association with Cardiometabolic Disorders. Molecules, 25.","DOI":"10.3390\/molecules25112555"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s11010-009-0219-x","article-title":"Nitric oxide and nitric oxide synthase isoforms in the normal, hypertrophic, and failing heart","volume":"333","author":"Umar","year":"2010","journal-title":"Mol. Cell Biochem."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1615\/CritRevOncog.2019031256","article-title":"Type 2 Diabetes and Cancer: The Nitric Oxide Connection","volume":"24","author":"Bahadoran","year":"2019","journal-title":"Crit. Rev. Oncog."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1089\/ars.2009.2453","article-title":"The role of nitric oxide in myocardial repair and remodeling","volume":"11","author":"Otani","year":"2009","journal-title":"Antioxid. Redox. Signal."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.freeradbiomed.2004.02.071","article-title":"Upregulation of NAD(P)H oxidase 1 in hypoxia activates hypoxia-inducible factor 1 via increase in reactive oxygen species","volume":"36","author":"Goyal","year":"2004","journal-title":"Free Radic. Biol. Med."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"H2073","DOI":"10.1152\/ajpheart.00943.2006","article-title":"Reactive oxygen species-selective regulation of aortic inflammatory gene expression in Type 2 diabetes","volume":"292","author":"Du","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1161\/01.HYP.36.6.957","article-title":"Effect of antioxidant therapy on blood pressure and NO synthase expression in hypertensive rats","volume":"36","author":"Vaziri","year":"2000","journal-title":"Hypertension"},{"key":"ref_85","unstructured":"Hansen, B., and Shafrir, E. (2002). Hypothalamic role in the insulin resistance syndrome. Insulin Resistance and Insulin Resistance Syndrome, Frontiers in Animal Diabetes Research Series, Taylor and Francis."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"16810","DOI":"10.1038\/srep16810","article-title":"Diet composition, not calorie intake, rapidly alters intrinsic excitability of hypothalamic AgRP\/NPY neurons in mice","volume":"5","author":"Wei","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/ijo.2016.183","article-title":"High fat induces acute and chronic inflammation in the hypothalamus: Effect of high-fat diet, palmitate and TNF-alpha on appetite-regulating NPY neurons","volume":"41","author":"Dalvi","year":"2017","journal-title":"Int. J. Obes."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00360-012-0689-0","article-title":"Changes in diet, body mass and fatty acid composition during pre-hibernation in a subtropical bat in relation to NPY and AgRP expression","volume":"183","author":"Levin","year":"2013","journal-title":"J. Comp. Physiol. B"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.tem.2004.07.009","article-title":"Insulin and its evolving partnership with leptin in the hypothalamic control of energy homeostasis","volume":"15","author":"Niswender","year":"2004","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"531","DOI":"10.2337\/diab.45.4.531","article-title":"Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob\/ob mice","volume":"45","author":"Schwartz","year":"1996","journal-title":"Diabetes"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"5305","DOI":"10.1113\/jphysiol.2009.179192","article-title":"Hormone and glucose signalling in POMC and AgRP neurons","volume":"587","author":"Belgardt","year":"2009","journal-title":"J. Physiol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.cmet.2005.10.009","article-title":"Leptin regulates insulin sensitivity via phosphatidylinositol-3-OH kinase signaling in mediobasal hypothalamic neurons","volume":"2","author":"Morton","year":"2005","journal-title":"Cell Metab."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.2741\/3885","article-title":"Leptin receptor signaling: Pathways to leptin resistance","volume":"16","author":"Wauman","year":"2011","journal-title":"Front. Biosci."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.tem.2010.08.002","article-title":"Obesity and leptin resistance: Distinguishing cause from effect","volume":"21","author":"Myers","year":"2010","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"4880","DOI":"10.1210\/en.2004-0726","article-title":"Region-specific leptin resistance within the hypothalamus of diet-induced obese mice","volume":"145","author":"Munzberg","year":"2004","journal-title":"Endocrinology"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.npep.2012.09.004","article-title":"Arcuate NPY neurons sense and integrate peripheral metabolic signals to control feeding","volume":"46","author":"Kohno","year":"2012","journal-title":"Neuropeptides"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1002\/fsn3.1169","article-title":"Diet-induced DNA methylation within the hypothalamic arcuate nucleus and dysregulated leptin and insulin signaling in the pathophysiology of obesity","volume":"7","author":"Samodien","year":"2019","journal-title":"Food Sci. Nutr."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/j.neuroimage.2008.06.002","article-title":"Low dopamine striatal D2 receptors are associated with prefrontal metabolism in obese subjects: Possible contributing factors","volume":"42","author":"Volkow","year":"2008","journal-title":"Neuroimage"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/ijo.2012.128","article-title":"High fat\/carbohydrate ratio but not total energy intake induces lower striatal dopamine D2\/3 receptor availability in diet-induced obesity","volume":"37","author":"Eggels","year":"2013","journal-title":"Int. J. Obes."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"14875","DOI":"10.1073\/pnas.1004282107","article-title":"Synaptic input organization of the melanocortin system predicts diet-induced hypothalamic reactive gliosis and obesity","volume":"107","author":"Horvath","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"4458","DOI":"10.1038\/s41467-020-17720-5","article-title":"Transcriptomic analysis links diverse hypothalamic cell types to fibroblast growth factor 1-induced sustained diabetes remission","volume":"11","author":"Bentsen","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"9391","DOI":"10.1073\/pnas.0802679105","article-title":"MEF2C, a transcription factor that facilitates learning and memory by negative regulation of synapse numbers and function","volume":"105","author":"Barbosa","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1177\/0748730406293854","article-title":"SCN outputs and the hypothalamic balance of life","volume":"21","author":"Kalsbeek","year":"2006","journal-title":"J. Biol. Rhythm."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jphysparis.2007.05.004","article-title":"Orchestration of gene expression and physiology by the circadian clock","volume":"100","author":"Albrecht","year":"2006","journal-title":"J. Physiol. Paris"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0079-6123(06)53015-8","article-title":"Circadian timing in health and disease","volume":"153","author":"Maywood","year":"2006","journal-title":"Prog. Brain. Res."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.pcad.2013.04.001","article-title":"Chronobiology in aortic diseases\u2014\u201cIs this really a random phenomenon?\u201d","volume":"56","author":"Manfredini","year":"2013","journal-title":"Prog. Cardiovasc. Dis."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1017\/S1464793103006250","article-title":"The brain\u2019s calendar: Neural mechanisms of seasonal timing","volume":"79","author":"Hofman","year":"2004","journal-title":"Biol. Rev. Camb. Philos Soc."},{"key":"ref_108","first-page":"464","article-title":"Circadian rhythms regulate the expression of the thrifty genotype\/phenotype","volume":"4","author":"Meier","year":"1996","journal-title":"Diabetes Rev."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/0016-6480(67)90119-0","article-title":"Diurnal variations of the fattening response to prolactin in the white-throated sparrow, Zonotrichia albicollis","volume":"8","author":"Meier","year":"1967","journal-title":"Gen. Comp. Endocrinol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/0016-6480(72)90180-3","article-title":"Temporal synergism of prolactin and adrenal steroids","volume":"3","author":"Meier","year":"1972","journal-title":"Gen. Comp. Endocrinol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3181\/00379727-137-35589","article-title":"Temporal synergism of prolactin and adrenal steroids in the regulation of fat stores","volume":"137","author":"Meier","year":"1971","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1677\/joe.0.1200385","article-title":"Properly timed injections of cortisol and prolactin produce long-term reductions in obesity, hyperinsulinaemia and insulin resistance in the Syrian hamster (Mesocricetus auratus)","volume":"120","author":"Cincotta","year":"1989","journal-title":"J. Endocrinol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"E2293","DOI":"10.1210\/jc.2012-2404","article-title":"Phase difference between serum prolactin and cortisol rhythms is related to body mass index in humans","volume":"97","author":"Roelfsema","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1126\/science.173.4003.1240","article-title":"Temporal synergism of corticosterone and prolactin controlling gonadal growth in sparrows","volume":"173","author":"Meier","year":"1971","journal-title":"Science"},{"key":"ref_115","first-page":"303","article-title":"Circadian organization of the avian annual cycle","volume":"Volume 2","author":"Johnston","year":"1984","journal-title":"Current Ornithology"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1080\/07420529309059707","article-title":"Circadian neuroendocrine role in age-related changes in body fat stores and insulin sensitivity of the male Sprague-Dawley rat","volume":"10","author":"Cincotta","year":"1993","journal-title":"Chronobiol. Int."},{"key":"ref_117","unstructured":"Gaillard, P.J., and Boer, H.H. (1978). Circadian hormone basis for seasonal conditions in the gulf killifish, Fundulus grandis. Comparative Endocrinology, Elsevier\/North Holland Biomedical Press."},{"key":"ref_118","first-page":"453","article-title":"Circadian components of the circannual mechanism in the white-throated sparrow","volume":"Volume 1","author":"Nohring","year":"1981","journal-title":"Acta XVII Congressus Internationalis Ornithologia"},{"key":"ref_119","first-page":"2912","article-title":"Influence of prolactin on dopaminergic neuronal systems in the hypothalamus","volume":"39","author":"Moore","year":"1980","journal-title":"Fed. Proc."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000122379","article-title":"Effect of adrenocorical hormones on activity of the serotonergic system in limbic structures","volume":"18","author":"Telegdy","year":"1975","journal-title":"Neuroendocrinology"},{"key":"ref_121","unstructured":"Ali, M.A. (1993). Circadian basis for neuroendocrine regulation. Proceedings International Symposium on Rhythms in Fishes, Plenum."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3109\/07420528909064621","article-title":"Resetting the annual cycle with timed daily injections of 5-hydroxytryptophan and L-dihydroxyphenylalanine in Syrian hamsters","volume":"6","author":"Wilson","year":"1989","journal-title":"Chronobiol. Int."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/09291018309359800","article-title":"Temporal synergism of neurotransmitter-affecting drugs influences seasonal conditions in sparrows","volume":"14","author":"Miller","year":"1982","journal-title":"J. Interdiscipl. Cycle Res."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/jez.1402330106","article-title":"Temporal variations in gonadal and body fat responses to daily injections of 5-hydroxytryptophan (5-HTP) and dihydroxyphenylalanine (DOPA) in the gulf killifish, Fundulus grandis","volume":"233","author":"Emata","year":"1985","journal-title":"J. Exp. Zool."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1037\/a0013111","article-title":"Exposure to elevated levels of dietary fat attenuates psychostimulant reward and mesolimbic dopamine turnover in the rat","volume":"122","author":"Davis","year":"2008","journal-title":"Behav. Neurosci."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.brainres.2010.06.036","article-title":"Effects of dietary fat and enterostatin on dopamine and 5-hydroxytrytamine release from rat striatal slices","volume":"1349","author":"York","year":"2010","journal-title":"Brain Res."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1126\/science.1239275","article-title":"A gut lipid messenger links excess dietary fat to dopamine deficiency","volume":"341","author":"Tellez","year":"2013","journal-title":"Science"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/sj.ijo.0800893","article-title":"Biochemical mechanisms responsible for the attenuation of diabetic and obese conditions in ob\/ob mice treated with dopaminergic agonists","volume":"23","author":"Scislowski","year":"1999","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s000180050197","article-title":"Bromocriptine\/SKF38393 ameliorates islet dysfunction in the diabetic (db\/db) mouse","volume":"54","author":"Liang","year":"1998","journal-title":"Cell Mol. Life Sci."},{"key":"ref_130","first-page":"A318","article-title":"Dopamine agonist treatment ameliorates the obese hyperglycemic condition in lethal yellow (A y\/a) mice","volume":"47","author":"Cincotta","year":"1998","journal-title":"Diabetes"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"E62","DOI":"10.1152\/ajpendo.00325.2019","article-title":"Bromocriptine improves glucose tolerance independent of circadian timing, prolactin, or the melanocortin-4 receptor","volume":"318","author":"Bakke","year":"2020","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"4445","DOI":"10.1210\/jc.2003-032184","article-title":"Prolactin release is enhanced in proportion to excess visceral fat in obese women","volume":"89","author":"Kok","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/17446651.2018.1434412","article-title":"The effects of hyperprolactinemia and its control on metabolic diseases","volume":"13","author":"Auriemma","year":"2018","journal-title":"Expert Rev. Endocrinol. Metab."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s12020-013-9914-1","article-title":"Metabolic syndrome associated with hyperprolactinemia: A new indication for dopamine agonist treatment?","volume":"44","author":"Bernabeu","year":"2013","journal-title":"Endocrine"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s11102-010-0277-9","article-title":"Insulin sensitivity and lipid profile in prolactinoma patients before and after normalization of prolactin by dopamine agonist therapy","volume":"14","author":"Berinder","year":"2011","journal-title":"Pituitary"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1365-2265.1995.tb00541.x","article-title":"Peripheral glucose metabolism in human hyperprolactinaemia","volume":"43","author":"Foss","year":"1995","journal-title":"Clin. Endocrinol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0015-0282(16)49291-5","article-title":"Decreased sensitivity to insulin in women with microprolactinomas","volume":"45","author":"Serri","year":"1986","journal-title":"Fertil. Steril."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/oby.2010.150","article-title":"BMI and metabolic profile in patients with prolactinoma before and after treatment with dopamine agonists","volume":"19","author":"Barbosa","year":"2011","journal-title":"Obesity"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1159\/000336501","article-title":"Central prolactin modulates insulin sensitivity and insulin secretion in diabetic rats","volume":"95","author":"Park","year":"2012","journal-title":"Neuroendocrinology"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1517\/13543784.8.10.1683","article-title":"Bromocriptine improves glycaemic control and serum lipid profile in obese Type 2 diabetic subjects: A new approach in the treatment of diabetes","volume":"8","author":"Cincotta","year":"1999","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1210\/endo.136.5.7720666","article-title":"The immunoregulatory effects of prolactin in mice are time of day dependent","volume":"136","author":"Cincotta","year":"1995","journal-title":"Endocrinology"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.neuron.2006.03.041","article-title":"A clock shock: Mouse CLOCK is not required for circadian oscillator function","volume":"50","author":"Debruyne","year":"2006","journal-title":"Neuron"},{"key":"ref_143","first-page":"270","article-title":"Synchronization and genetic redundancy in circadian clocks","volume":"24","author":"Dardente","year":"2008","journal-title":"Med. Sci."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nn1884","article-title":"CLOCK and NPAS2 have overlapping roles in the suprachiasmatic circadian clock","volume":"10","author":"DeBruyne","year":"2007","journal-title":"Nat. Neurosci."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1530\/EC-16-0051","article-title":"Bromocriptine and insulin sensitivity in lean and obese subjects","volume":"5","author":"Bahler","year":"2016","journal-title":"Endocr. Connect."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"pyv014","DOI":"10.1093\/ijnp\/pyv014","article-title":"Reduced insulin sensitivity is related to less endogenous dopamine at D2\/3 receptors in the ventral striatum of healthy nonobese humans","volume":"18","author":"Caravaggio","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"eaar3752","DOI":"10.1126\/scitranslmed.aar3752","article-title":"Striatal dopamine regulates systemic glucose metabolism in humans and mice","volume":"10","author":"Lammers","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijcard.2004.05.010","article-title":"An affected pedigree member analysis of linkage between the dopamine D2 receptor gene TaqI polymorphism and obesity and hypertension","volume":"102","author":"Fang","year":"2005","journal-title":"Int. J. Cardiol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"6711","DOI":"10.1523\/JNEUROSCI.0045-12.2012","article-title":"Evidence that sleep deprivation downregulates dopamine D2R in ventral striatum in the human brain","volume":"32","author":"Volkow","year":"2012","journal-title":"J. Neurosci."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"368","DOI":"10.3109\/13880209.2013.837492","article-title":"Stress-mediated modulations in dopaminergic system and their subsequent impact on behavioral and oxidative alterations: An update","volume":"52","author":"Alghasham","year":"2014","journal-title":"Pharm. Biol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.2337\/db13-1546","article-title":"Circadian misalignment augments markers of insulin resistance and inflammation, independently of sleep loss","volume":"63","author":"Leproult","year":"2014","journal-title":"Diabetes"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.1073\/pnas.0808180106","article-title":"Adverse metabolic and cardiovascular consequences of circadian misalignment","volume":"106","author":"Scheer","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_153","first-page":"46","article-title":"Chronic stress and insulin resistance-related indices of cardiovascular disease risk, part I: Neurophysiological responses and pathological sequelae","volume":"13","author":"Innes","year":"2007","journal-title":"Altern. Ther. Health Med."},{"key":"ref_154","first-page":"44","article-title":"Chronic stress and insulin resistance-related indices of cardiovascular disease risk, part 2: A potential role for mind-body therapies","volume":"13","author":"Innes","year":"2007","journal-title":"Altern. Ther. Health Med."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/11\/6142\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:11:38Z","timestamp":1760163098000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/11\/6142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,7]]},"references-count":154,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,6]]}},"alternative-id":["ijms22116142"],"URL":"https:\/\/doi.org\/10.3390\/ijms22116142","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,7]]}}}